These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 37549462

  • 1. Dexmedetomidine abates myocardial ischemia reperfusion injury through inhibition of pyroptosis via regulation of miR-665/MEF2D/Nrf2 axis.
    Wang L, Liu J, Wang Z, Qian X, Zhao Y, Wang Q, Dai N, Xie Y, Zeng W, Yang W, Bai X, Yang Y, Qian J.
    Biomed Pharmacother; 2023 Sep; 165():115255. PubMed ID: 37549462
    [Abstract] [Full Text] [Related]

  • 2. Dexmedetomidine inhibits pyroptosis by down-regulating miR-29b in myocardial ischemia reperfusion injury in rats.
    Zhong Y, Li YP, Yin YQ, Hu BL, Gao H.
    Int Immunopharmacol; 2020 Sep; 86():106768. PubMed ID: 32679539
    [Abstract] [Full Text] [Related]

  • 3. Dexmedetomidine attenuates myocardial ischemia/reperfusion-induced ferroptosis via AMPK/GSK-3β/Nrf2 axis.
    Wang Z, Yao M, Jiang L, Wang L, Yang Y, Wang Q, Qian X, Zhao Y, Qian J.
    Biomed Pharmacother; 2022 Oct; 154():113572. PubMed ID: 35988428
    [Abstract] [Full Text] [Related]

  • 4. Dexmedetomidine protects H9C2 against hypoxia/reoxygenation injury through miR-208b-3p/Med13/Wnt signaling pathway axis.
    Wang Z, Yang Y, Xiong W, Zhou R, Song N, Liu L, Qian J.
    Biomed Pharmacother; 2020 May; 125():110001. PubMed ID: 32070878
    [Abstract] [Full Text] [Related]

  • 5. Oxytocin ameliorates high glucose- and ischemia/reperfusion-induced myocardial injury by suppressing pyroptosis via AMPK signaling pathway.
    Yao M, Wang Z, Jiang L, Wang L, Yang Y, Wang Q, Qian X, Zeng W, Yang W, Liang R, Qian J.
    Biomed Pharmacother; 2022 Sep; 153():113498. PubMed ID: 36076588
    [Abstract] [Full Text] [Related]

  • 6. LncRNA Rian reduces cardiomyocyte pyroptosis and alleviates myocardial ischemia-reperfusion injury by regulating by the miR-17-5p/CCND1 axis.
    Kang H, Yu H, Zeng L, Ma H, Cao G.
    Hypertens Res; 2022 Jun; 45(6):976-989. PubMed ID: 35264782
    [Abstract] [Full Text] [Related]

  • 7. Sevoflurane exerts protection against myocardial ischemia-reperfusion injury and pyroptosis through the circular RNA PAN3/microRNA-29b-3p/stromal cell-derived factor 4 axis.
    An L, Zhong Y, Tan J, Liu Y, Li A, Yang T, Wang S, Liu Y, Gao H.
    Int Immunopharmacol; 2023 Jul; 120():110219. PubMed ID: 37270931
    [Abstract] [Full Text] [Related]

  • 8. Dexmedetomidine alleviates hepatic ischaemia-reperfusion injury via the PI3K/AKT/Nrf2-NLRP3 pathway.
    Wu Y, Qiu G, Zhang H, Zhu L, Cheng G, Wang Y, Li Y, Wu W.
    J Cell Mol Med; 2021 Nov; 25(21):9983-9994. PubMed ID: 34664412
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Suxiao Jiuxin Pill alleviates myocardial ischemia/reperfusion-induced autophagy via miR-193a-3p/ALKBH5 pathway.
    Wang D, Wang D, Jin Q, Wang X.
    Phytomedicine; 2024 Mar; 125():155359. PubMed ID: 38301300
    [Abstract] [Full Text] [Related]

  • 11. Dexmedetomidine Alleviates Brain Ischemia/Reperfusion Injury by Regulating Metastasis-associated Lung Adenocarcinoma Transcript 1/MicroRNA-140-5p/ Nuclear Factor Erythroid-derived 2-like 2 Axis.
    Qin Z, Xu Y.
    Protein Pept Lett; 2024 Mar; 31(2):116-127. PubMed ID: 38083898
    [Abstract] [Full Text] [Related]

  • 12. Dexmedetomidine Attenuates Hypoxia/Reoxygenation Injury of H9C2 Myocardial Cells by Upregulating miR-146a Expression via the MAPK Signal Pathway.
    Chu Y, Teng J, Feng P, Liu H, Wang F, Wang H.
    Pharmacology; 2022 Mar; 107(1-2):14-27. PubMed ID: 34718238
    [Abstract] [Full Text] [Related]

  • 13. Role of Keap1-Nrf2/ARE signal transduction pathway in protection of dexmedetomidine preconditioning against myocardial ischemia/reperfusion injury.
    Li HX, Wang TH, Wu LX, Xue FS, Zhang GH, Yan T.
    Biosci Rep; 2022 Sep 30; 42(9):. PubMed ID: 35959640
    [Abstract] [Full Text] [Related]

  • 14. Dexmedetomidine alleviates myocardial ischemia/reperfusion-induced injury and Ca2+ overload via the microRNA-346-3p/CaMKIId axis.
    Zheng X, Li J, Fan Q, Zhao X, Chen K.
    Int J Cardiol; 2021 Sep 01; 338():185-195. PubMed ID: 33731281
    [Abstract] [Full Text] [Related]

  • 15. Dexmedetomidine alleviates myocardial ischemia-reperfusion injury by down-regulating miR-34b-3p to activate the Jagged1/Notch signaling pathway.
    Guo P, Yi H, Han M, Liu X, Chen K, Qing J, Yang F.
    Int Immunopharmacol; 2023 Mar 01; 116():109766. PubMed ID: 36764271
    [Abstract] [Full Text] [Related]

  • 16. cFLIPL alleviates myocardial ischemia-reperfusion injury by regulating pyroptosis.
    Zhang D, Wu H, Liu D, Ye M, Li Y, Zhou G, Yang Q, Liu Y, Li Y.
    Cell Biol Int; 2024 Jan 01; 48(1):60-75. PubMed ID: 37750485
    [Abstract] [Full Text] [Related]

  • 17. hUC-MSC-EV-miR-24 enhances the protective effect of dexmedetomidine preconditioning against myocardial ischemia-reperfusion injury through the KEAP1/Nrf2/HO-1 signaling.
    Hou Z, Yang F, Chen K, Wang Y, Qin J, Liang F.
    Drug Deliv Transl Res; 2024 Jan 01; 14(1):143-157. PubMed ID: 37540334
    [Abstract] [Full Text] [Related]

  • 18. Dexmedetomidine alleviates pulmonary ischemia-reperfusion injury through modulating the miR-21-5p/Nr4a1 signaling pathway.
    Dong W, Yang H, Cheng M, Zhang X, Yin J, Zeng Z, Huang G.
    Acta Biochim Pol; 2020 Dec 17; 67(4):521-529. PubMed ID: 33332077
    [Abstract] [Full Text] [Related]

  • 19. Exosomal miR-27b-3p Derived from Hypoxic Cardiac Microvascular Endothelial Cells Alleviates Rat Myocardial Ischemia/Reperfusion Injury through Inhibiting Oxidative Stress-Induced Pyroptosis via Foxo1/GSDMD Signaling.
    Zhang B, Sun C, Liu Y, Bai F, Tu T, Liu Q.
    Oxid Med Cell Longev; 2022 Dec 17; 2022():8215842. PubMed ID: 35847592
    [Abstract] [Full Text] [Related]

  • 20. Dexmedetomidine exerts cardioprotective effect through miR-146a-3p targeting IRAK1 and TRAF6 via inhibition of the NF-κB pathway.
    He L, Wang Z, Zhou R, Xiong W, Yang Y, Song N, Qian J.
    Biomed Pharmacother; 2021 Jan 17; 133():110993. PubMed ID: 33220608
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.